FTC 'Close' To Final PBM Insulin Price Deal With OptumRx
By Bryan Koenig · May 20, 2026, 4:38 PM EDT
Federal Trade Commission staffers have signaled that they're near a settlement with UnitedHealth Group Inc.'s OptumRx that would close out the agency's in-house case accusing pharmacy benefit managers of inflating insulin...
To view the full article, register now.